HYTN Innovations Inc (TSE:HYTN) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
HYTN Innovations Inc., a leader in the pharmaceuticals sector focusing on psychoactive and psychotropic compounds including cannabinoids and psilocybin, has officially reported the acquisition of Prism Scientific Labs Inc. This strategic move, aimed at expanding HYTN’s market presence, underscores the company’s commitment to innovation and growth in the regulated markets of these specialized compounds.
For further insights into TSE:HYTN stock, check out TipRanks’ Stock Analysis page.
